Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bukowski

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Cancer|December 15, 1987
A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group StudyR M Bukowski, K G Johnson, R F Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusionsA Bhatia, T W Rice, D McLain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effectsT Olencki, J Finke, R Tubbs, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancerR Pelley, R Ganapathi, L Wood, et al.
Seminars in Hematology|July 1, 1976
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpuraR M Bukowski, J S Hewlett, J W Harris, et al.
Cancer|March 15, 1996
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinomaE Wos, T Olencki, L Tuason, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
The Annals of Thoracic Surgery|March 1, 1995
Expression of blood group antigen A by stage I non-small cell lung carcinomasT W Rice, R R Tubbs, G A Hoeltge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group StudyG E Goodman, J J Crowley, J C Blasko, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Cancer|December 15, 1987
A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group StudyR M Bukowski, K G Johnson, R F Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusionsA Bhatia, T W Rice, D McLain, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effectsT Olencki, J Finke, R Tubbs, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancerR Pelley, R Ganapathi, L Wood, et al.
Seminars in Hematology|July 1, 1976
Exchange transfusions in the treatment of thrombotic thrombocytopenic purpuraR M Bukowski, J S Hewlett, J W Harris, et al.
Cancer|March 15, 1996
Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinomaE Wos, T Olencki, L Tuason, et al.
Investigational New Drugs|May 1, 1993
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinomaR M Bukowski, J Young, G Goodman, et al.
The Annals of Thoracic Surgery|March 1, 1995
Expression of blood group antigen A by stage I non-small cell lung carcinomasT W Rice, R R Tubbs, G A Hoeltge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group StudyG E Goodman, J J Crowley, J C Blasko, et al.
Pageof 17